Shares of Integer Holdings Corporation (NYSE:ITGR – Get Free Report) have earned an average recommendation of “Hold” from the ten research firms that are presently covering the firm, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $102.00.
A number of equities analysts recently commented on ITGR shares. Truist Financial boosted their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Wall Street Zen downgraded Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Wells Fargo & Company upped their price objective on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Raymond James Financial reiterated an “outperform” rating and issued a $101.00 price objective on shares of Integer in a report on Monday, February 23rd. Finally, Citigroup raised their target price on Integer from $75.00 to $92.00 and gave the stock a “neutral” rating in a research report on Friday, February 20th.
Check Out Our Latest Report on Integer
Insider Buying and Selling
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of ITGR. Salomon & Ludwin LLC acquired a new stake in Integer during the 3rd quarter worth $26,000. Global Retirement Partners LLC lifted its position in Integer by 293.8% in the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 238 shares during the last quarter. TD Private Client Wealth LLC boosted its stake in Integer by 1,037.5% in the fourth quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 415 shares in the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Integer by 135.5% during the fourth quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 267 shares during the last quarter. Finally, Arax Advisory Partners grew its holdings in shares of Integer by 2,489.5% during the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 473 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.
Integer Stock Down 0.2%
ITGR stock opened at $84.20 on Friday. The company’s 50 day moving average price is $85.55 and its 200 day moving average price is $85.05. The firm has a market capitalization of $2.90 billion, a price-to-earnings ratio of 29.34, a PEG ratio of 1.43 and a beta of 0.75. Integer has a fifty-two week low of $62.00 and a fifty-two week high of $127.56. The company has a debt-to-equity ratio of 0.69, a quick ratio of 2.23 and a current ratio of 3.32.
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.06. Integer had a net margin of 5.55% and a return on equity of 13.26%. The company had revenue of $472.06 million during the quarter, compared to the consensus estimate of $462.73 million. During the same quarter in the previous year, the firm earned $1.43 earnings per share. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. On average, equities research analysts anticipate that Integer will post 6.01 EPS for the current fiscal year.
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
